Hyperlipidemia, hyperlipemia, and hepatic lipidosis in American Miniature Horses: 23 cases (1990–1994)
Key result
Peak serum triglycerides above 1200 mg/dl linked to complete mortality in horses.
- n=23
Why the study?
American Miniature Horses can rapidly develop hyperlipidemia or hyperlipemia during negative energy balance, but clinical characteristics and outcomes were not well described.
Population
23 American Miniature Horses with hyperlipidemia, hyperlipemia, or hepatic lipidosis
Comparison
Not applicable; observational case series
Design
Retrospective case series
Authors
Discussion
Loading...
Member takes
Implication
Secondary causes like enterocolitis predominate; leaves open optimal management of primary hyperlipemia cases.
Study Design
Type
Observational (n=23)
Structured PICO
P
Population
23 American Miniature Horses with hyperlipidemia, hyperlipemia, or hepatic lipidosis evaluated between 1990 and 1994.
E
Exposure
Dextrose, heparin, and insulin (most common treatments)
O
Outcome
Survivalhard clinical
In American Miniature Horses with hyperlipidemia or hyperlipemia, peak serum triglyceride concentrations > 1,200 mg/dl are associated with 100% mortality.
Cite This Study
Mogg et al. (1995) conducted an observational in Hyperlipidemia, hyperlipemia, or hepatic lipidosis (n=23). Peak serum triglyceride concentrations > 1,200 mg/dl vs. Peak serum triglyceride concentrations < 1,200 mg/dl was evaluated on Overall survival. Overall survival was 61% (14/23), with 100% mortality in horses with peak serum triglyceride concentrations > 1,200 mg/dl compared to near complete survival in those with < 1,200 mg/dl.